Skip to content

RENOVACARE, INC.: 10-Q filed 2020-08-13

What RENOVACARE, INC. reported in its quarterly report filed 2020-08-13 (fiscal Q2 2020): 21 published measures, 61 facts as tagged in accession 0001171843-20-005919.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-13
Fiscal period
fiscal Q2 2020
Accession
0001171843-20-005919 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RENOVACARE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-3010,823,102USD
At 2019-12-3112,440,602USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-30797,301USD
At 2019-12-31280,740USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-3010,025,801USD
At 2020-03-3111,450,872USD
At 2019-12-3112,159,862USD
At 2019-06-3014,260,751USD
At 2019-03-3114,780,017USD
At 2018-12-3115,326,689USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,011,593USD91
2020-01-01 to 2020-06-30-4,186,346USD182
2020-01-01 to 2020-03-31-1,174,753USD91
2019-04-01 to 2019-06-30-547,504USD91
2019-01-01 to 2019-06-30-1,066,770USD181
2019-01-01 to 2019-03-31-547,504USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-1,919,185USD182
2019-01-01 to 2019-06-30-1,124,942USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-7,995USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-24,406,191USD
At 2019-12-31-20,219,845USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-04-01 to 2020-06-3087,352,364shares91
2020-01-01 to 2020-06-3087,352,364shares182
2019-04-01 to 2019-06-3087,175,522shares91
2019-01-01 to 2019-06-3087,175,522shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,586,522USD91
2020-01-01 to 2020-03-31465,763USD91
2019-01-01 to 2019-03-31832USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,044,481USD91
2020-01-01 to 2020-06-30-4,272,820USD182
2019-04-01 to 2019-06-30-643,528USD91
2019-01-01 to 2019-06-30-1,247,499USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-3010,662,253USD
At 2019-12-3112,287,748USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-30797,301USD
At 2019-12-31280,740USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-303,044,481USD91
2020-01-01 to 2020-06-304,272,820USD182
2019-04-01 to 2019-06-30643,528USD91
2019-01-01 to 2019-06-301,247,499USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,347,005USD91
2020-01-01 to 2020-06-301,539,778USD182
2019-04-01 to 2019-06-30179,193USD91
2019-01-01 to 2019-06-30373,702USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-3087,352,364shares
At 2019-12-3187,352,364shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-3034,431,118USD
At 2019-12-3132,378,833USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-06-30152,854USD
At 2019-12-31152,854USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,697,476USD91
2020-01-01 to 2020-06-302,733,042USD182
2019-04-01 to 2019-06-30464,335USD91
2019-01-01 to 2019-06-30873,797USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-06-30158USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-3032,888USD91
2020-01-01 to 2020-06-3086,474USD182
2019-04-01 to 2019-06-3096,024USD91
2019-01-01 to 2019-06-30180,729USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30497,738USD182
2019-01-01 to 2019-06-30-43,822USD181

Inspect the source

Entity
RENOVACARE, INC. / CIK 0001016708
Captured
SEC response SHA-256
9487b64abbea883e1831cb5c68f7e4fad6892ca4a6b733f29ee7e3c3b50f65e4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001016708.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))